Drugs / SAS0421b
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03892772 | Jan 2019 → Jul 2021 | sleep apnea syndrome | Brigham and Women's Hospital | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAS0421b | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03892772 ↗ |